Description
Chair: Marco Durante (GSI and TU Darmstadt), Rapporteur: Bleddyn Jones (Univ.of Oxford)
-
Gillies McKenna (Gray Institute for Radiation Oncology & Biology, Oxford)02/02/2010, 13:30
-
Oliver Jaekel (DKFZ, Heidelberg)02/02/2010, 14:00
-
Dr Gisela Taucher-Scholz (GSI Biophysics, Darmstadt, Germany)02/02/2010, 14:30Radiobiology in therapy and space scienceOral presentationsDouble-strand breaks (DBSs) are critical lesions and their spatial distribution is crucial regarding repair capability and biological effects. Ion irradiation leads to streaks of spatially localized damaged chromatin domains across cell nuclei revealed by repair protein immunostaining. Efficient repair after carbon ion irradiation is indicated by loss of the DSB marker H2AX, but repair is...Go to contribution page
-
Dr Petteri Nieminen (ESA)02/02/2010, 14:45Radiobiology in therapy and space scienceOral presentationsThe space radiation environment is a highly variable and dynamic one, with a number of constituent particle sources that need to be individually considered depending on the type of space mission planned. The Galactic Cosmic Rays form a slowly varying higher-energy background over the 11-year solar cycle, on top of which the sporadic, lower-energy, but essentially unpredictable Solar Particle...Go to contribution page
-
Dr Marco Silari (CERN)02/02/2010, 15:00Radiobiology in therapy and space scienceThe feasibility is presented of setting-up an experimental facility at CERN, to be made available to European institutes, for research in radiobiology and dosimetry with light-ion beams, with minimum impact on CERN main activities. The possibility is first discussed of injecting and decelerating protons rather than antiprotons in the AD, providing beams with kinetic energies in the range 5–300...Go to contribution page
-
Dr Giuseppe Battistoni (INFN MILANO)02/02/2010, 15:45Radiobiology in therapy and space scienceBiological calculations in tumour therapy with ions depend on a precise description of the radiation field. In carbon ion irradiation, nuclear reactions cause a significant alteration of the radiation field. Therefore, the contribution of secondary fragments needs to be taken into account for accurate planning of the physical and biological dose delivery in the scheduled treatment....Go to contribution page
-
Dr Michael KRAEMER (GSI)02/02/2010, 16:00Radiobiology in therapy and space scienceOral presentationsA major issue of modern radiotherapy is the delivery of sufficiently high dose to the target, whereas the exposure of healthy tissue should be minimized. Swift light ions offer significant physical and radiobiological advantages compared to photon radiation. So far the technologically most advanced project to apply charged particles in radiotherapy was the GSI pilot project, now followed...Go to contribution page
-
Dr Andrea Attili (on behalf of the INFN-TPS collaboration)02/02/2010, 16:15Radiobiology in therapy and space scienceOral presentationsSeveral technologies developed by the Italian institute of nuclear physics (INFN) for fundamental physics have been applied to medical imaging and particle therapy techniques. The partnership with leading industries has always been crucial for successful applications. Within this framework is the implementation of a Treatment Planning System (TPS) for hadrontherapy with C-ion beams, but not...Go to contribution page
-
Dr Yolanda Prezado (European synchrotron Radiation Facility)02/02/2010, 16:30Radiobiology in therapy and space scienceOral presentationsSynchrotron radiation (SR) therapy is a promising alternative to treat brain tumors, whose management is limited due to the high morbidity of the surrouding healthy tissues. Several approaches are being explored by using SR. The European Synchrotron Radiation Facility (ESRF) in Grenoble (France) has devoted one of its lines to biomedical research, highly focused nowadays to the development of...Go to contribution page
-
02/02/2010, 16:45
-
02/02/2010, 17:00
-
02/02/2010, 17:30